Home / Governance / Lewis Hsu
Lewis Hsu
US representative
Lewis Hsu, MD, PhD, is director of pediatric sickle cell and professor at University of Illinois at Chicago. His research in sickle cell disease includes community health workers, implementation science, health education, stroke risk, pain management, and vasculopathy in mouse models. He co-authored the “Hope and Destiny” books for family education on sickle cell. His community engagement and volunteer service includes Sickle Cell Disease Association of America and global experience at 3 sites in Nigeria plus Brazil. This broad experience with training, engaging stakeholder groups, and clinical care qualifies Dr. Hsu to collaborate in the ARISE program.
Latest News & Events
Keep updated on all the initiatives and events of the ARISE project
SAVE THE DATE – ASCAT Conference 2023
The ASCAT conference “Therapeutic Strategies For Sickle Cell Disease & Thalassaemia: Time to Consider A Multi-Modal & Personalised Approach” will be held on 25-28 October in London.
Third International Summit on Human Genome Editing (6-8 March 2023)
The Third International Summit on Human Genome Editing took place in London, UK on March 6-8, 2023.
SAVE THE DATE: Sickle Cell & Thalassaemia course
A two-day training course on Sickle Cell Disease and Thalassaemia will run virtually on 17th-18th October 2022. The course is organised by South Thames Sickle Cell & Thalassemia Network.